
### [NCIT:C27897](http://purl.obolibrary.org/obo/NCIT_C27897)
**Label:** T-Cell Proliferation of Uncertain Malignant Potential

**Subclasses:** [NCIT:C3721](http://purl.obolibrary.org/obo/NCIT_C3721) (Lymphomatoid Papulosis), [NCIT:C139014](http://purl.obolibrary.org/obo/NCIT_C139014) (Type D Lymphomatoid Papulosis), [NCIT:C139015](http://purl.obolibrary.org/obo/NCIT_C139015) (Type E Lymphomatoid Papulosis), [NCIT:C7197](http://purl.obolibrary.org/obo/NCIT_C7197) (Type A Lymphomatoid Papulosis), [NCIT:C7196](http://purl.obolibrary.org/obo/NCIT_C7196) (Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder), [NCIT:C7199](http://purl.obolibrary.org/obo/NCIT_C7199) (Type C Lymphomatoid Papulosis), [NCIT:C7198](http://purl.obolibrary.org/obo/NCIT_C7198) (Type B Lymphomatoid Papulosis), 

**Class expressions from DL-Learner:**

- Thing 53.67%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 37.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40015](http://purl.obolibrary.org/obo/NCIT_C40015) (Ovarian Mucinous Carcinoid Tumor))) 37.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40014](http://purl.obolibrary.org/obo/NCIT_C40014) (Ovarian Trabecular Carcinoid Tumor))) 37.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39991](http://purl.obolibrary.org/obo/NCIT_C39991) (Non-Gestational Ovarian Choriocarcinoma))) 37.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39989](http://purl.obolibrary.org/obo/NCIT_C39989) (Ovarian Yolk Sac Tumor, Hepatoid Pattern))) 37.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39988](http://purl.obolibrary.org/obo/NCIT_C39988) (Ovarian Yolk Sac Tumor, Glandular Pattern))) 37.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39985](http://purl.obolibrary.org/obo/NCIT_C39985) (Ovarian Gonadoblastoma))) 37.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3998](http://purl.obolibrary.org/obo/NCIT_C3998) (Recurrent Colon Carcinoma))) 37.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39966](http://purl.obolibrary.org/obo/NCIT_C39966) (Ovarian Sertoli-Stromal Cell Tumor))) 37.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39963](http://purl.obolibrary.org/obo/NCIT_C39963) (Penile Bowenoid Papulosis))) 37.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39961](http://purl.obolibrary.org/obo/NCIT_C39961) (Penile Basal Cell Carcinoma))) 37.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39959](http://purl.obolibrary.org/obo/NCIT_C39959) (Mixed Squamous Cell Carcinoma of the Penis))) 37.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39957](http://purl.obolibrary.org/obo/NCIT_C39957) (Epididymal Adenocarcinoma))) 37.74%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39956](http://purl.obolibrary.org/obo/NCIT_C39956) (Rete Testis Adenoma))) 37.74%


